MTlogo w ABT.jpg
  • Home

  • Team

  • Technology

  • Portfolio

  • Partnering

  • News

  • Contact

  • Career

  • Chinese

  • More

    Use tab to navigate through the menu items.
    • White Facebook Icon
    • White Twitter Icon
    • White Google+ Icon
    • White Instagram Icon

    Multitude Therapeutics

    Innovative, Effective Drugs for the great multitude

    About Us

    Multitude Therapeutics (MTX) is a spinoff company from the Therapeutics division of Abmart to leverage its unparalleled target and antibody discovery capability for cancer immunotherapy.  MTX focuses on developing antibody-drug conjugates (ADC), bispecific antibodies, and CAR-Ts for solid and hematological tumors. MTX’s therapeutic programs are based on novel cancer cell surface targets discovered by monoclonal antibody arrays (Human Membrane Proteome MabArrayTM or HMP-MabArrayTM) powered by the exceptional antibody discovery capabilities built at Abmart. 

    Contact

    Thanks! Message sent.

    Address

    3698 Haven Avenue, Suite A

    Redwood City, CA  94063, USA
     

    Floor 1-3, Building 1, No 333 Guiping Road

    Shanghai 200233, China

     

    Email: info@multitudetherapeutics.com

    © 2020 Multitude Therapeutics. All Rights Reserved.